ArticleIn vivo (Athens, Greece)

The Combination Sorafenib-raloxifene-loratadine as a Novel Potential Therapeutic Approach Against Human Liver Cancer.

Fernanda Villarruel-Melquiades et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.